The first case of Mpox infection in Iran during the 2022 outbreak.

IF 1.4 4区医学 Q4 INFECTIOUS DISEASES

Journal of Infection in Developing Countries Pub Date : 2024-09-30 DOI:10.3855/jidc.18589

Ali Maleki, Arash Arashkia, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Mahsa Tavakoli, Mohammad Modoodi Yaghooti, Zahra Ahmadi, Farideh Niknam Oskouei, Zahra Fereydouni, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, Mahdi Rohani

{"title":"The first case of Mpox infection in Iran during the 2022 outbreak.","authors":"Ali Maleki, Arash Arashkia, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Mahsa Tavakoli, Mohammad Modoodi Yaghooti, Zahra Ahmadi, Farideh Niknam Oskouei, Zahra Fereydouni, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, Mahdi Rohani","doi":"10.3855/jidc.18589","DOIUrl":null,"url":null,"abstract":"Introduction: The unexpected outbreak of human Mpox infection beginning in some European countries that were non-endemic for Mpox stunned the world during the Coronavirus Disease 2019 (COVID-19) pandemic in May 2022. The re-emerging Mpox outbreak, which has a greater capacity for human-to-human transmission, was mainly due to traveling. In this paper, we describe the first case of the disease was observed in an Iranian woman infected by her husband who had a history of traveling to Canada.Case report: The 34-year-old woman had flu-like syndrome with some skin rashes on her hand, finger, and arm. No antivirals were prescribed in this case, and supportive care was used to help her recover. RT-PCR and Sanger sequencing were used to analyze the sample from the oropharyngeal swab and the rash, and the results confirmed the Mpox infection.Conclusions: The risk of infectious disease outbreaks after COVID-19, such as Mpox, is of great importance, and health systems should be vigilant for timely identification and preparedness.","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"18 9","pages":"1450-1452"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.18589","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The unexpected outbreak of human Mpox infection beginning in some European countries that were non-endemic for Mpox stunned the world during the Coronavirus Disease 2019 (COVID-19) pandemic in May 2022. The re-emerging Mpox outbreak, which has a greater capacity for human-to-human transmission, was mainly due to traveling. In this paper, we describe the first case of the disease was observed in an Iranian woman infected by her husband who had a history of traveling to Canada.

Case report: The 34-year-old woman had flu-like syndrome with some skin rashes on her hand, finger, and arm. No antivirals were prescribed in this case, and supportive care was used to help her recover. RT-PCR and Sanger sequencing were used to analyze the sample from the oropharyngeal swab and the rash, and the results confirmed the Mpox infection.

Conclusions: The risk of infectious disease outbreaks after COVID-19, such as Mpox, is of great importance, and health systems should be vigilant for timely identification and preparedness.

查看原文本刊更多论文

伊朗在 2022 年疫情爆发期间首次出现 Mpox 感染病例。

导言：2022 年 5 月，在 2019 年冠状病毒病（COVID-19）大流行期间，一些非痘病毒流行的欧洲国家意外爆发了人类痘病毒感染，震惊了世界。此次再次爆发的痘病毒疫情，其人传人的能力更强，主要是由于旅行造成的。在本文中，我们描述了在一名伊朗妇女身上观察到的首例病例，该妇女被其有加拿大旅行史的丈夫感染：这名 34 岁的妇女患有流感样综合征，手部、手指和手臂出现一些皮疹。该病例未使用抗病毒药物，而是采用支持性护理帮助她康复。对口咽拭子和皮疹样本进行了 RT-PCR 和 Sanger 测序分析，结果证实感染了 Mpox：结论：COVID-19 事件后爆发传染病（如麻风腮）的风险非常大，卫生系统应提高警惕，及时识别并做好准备。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Infection in Developing Countries INFECTIOUS DISEASES-

CiteScore

3.70

自引率

5.30%

发文量

239

审稿时长

4-8 weeks

期刊介绍： The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries. JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.